Literature DB >> 22049647

Chilean validation of the Posttraumatic Stress Disorder Checklist-Civilian version (PCL-C) after the earthquake on February 27, 2010.

Pablo Vera-Villarroel1, Izabela Zych, Karem Celis-Atenas, Natalia Córdova-Rubio, Gualberto Buela-Casal.   

Abstract

Posttraumatic stress disorder (PTSD) is an anxiety disorder in which an individual re-experiences a traumatic event, avoids situations related to it, and shows excessive arousal. The disorder appears after experiencing a life-threatening event, such as a war or a natural disaster. Thus, the validation of tests which assess the disorder after the earthquake on February 27, 2010, in Chile is crucial for its evaluation and subsequent intervention. The present study includes psychometric data for the Posttraumatic Stress Disorder Checklist-Civilian version (PCL-C) on a sample of 509 survivors of the disaster. Values indicate good psychometric properties of the questionnaire.

Entities:  

Mesh:

Year:  2011        PMID: 22049647     DOI: 10.2466/02.13.15.17.PR0.109.4.47-58

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  11 in total

1.  Social capital and chronic post-traumatic stress disorder among survivors of the 2007 earthquake in Pisco, Peru.

Authors:  Elaine C Flores; Andres M Carnero; Angela M Bayer
Journal:  Soc Sci Med       Date:  2013-11-15       Impact factor: 4.634

2.  Development of posttraumatic stress disorder and depression after open globe injury in adults.

Authors:  Ali Keles; Ali Karayagmurlu; Esat Yetkin; Kenan Sonmez; Mustafa Salih Karatepe; Suleyman Korhan Karaman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-08       Impact factor: 3.535

3.  Perceived Barriers and Preliminary PTSD Outcomes in an Open Pilot Trial of Written Exposure Therapy With Latinx Immigrants.

Authors:  Arthur R Andrews; Laura M Acosta; M Natalia Acosta Canchila; James K Haws; Kathryn J Holland; Natalie R Holt; Allura L Ralston
Journal:  Cogn Behav Pract       Date:  2021-06-20

4.  Longitudinal course of disaster-related PTSD among a prospective sample of adult Chilean natural disaster survivors.

Authors:  Cristina A Fernandez; Benjamin Vicente; Brandon Dl Marshall; Karestan C Koenen; Kristopher L Arheart; Robert Kohn; Sandra Saldivia; Stephen L Buka
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

5.  Applicability of the ICD-11 proposal for PTSD: a comparison of prevalence and comorbidity rates with the DSM-IV PTSD classification in two post-conflict samples.

Authors:  Nadine Stammel; Eva M Abbing; Carina Heeke; Christine Knaevelsrud
Journal:  Eur J Psychotraumatol       Date:  2015-05-18

6.  Validity of the posttraumatic stress disorders (PTSD) checklist in pregnant women.

Authors:  Bizu Gelaye; Yinnan Zheng; Maria Elena Medina-Mora; Marta B Rondon; Sixto E Sánchez; Michelle A Williams
Journal:  BMC Psychiatry       Date:  2017-05-12       Impact factor: 3.630

7.  Validation of the posttraumatic stress disorder checklist - 5 (PCL-5) in a primary care population with high HIV prevalence in Zimbabwe.

Authors:  Ruth Verhey; Dixon Chibanda; Lorna Gibson; Jonathan Brakarsh; Soraya Seedat
Journal:  BMC Psychiatry       Date:  2018-04-23       Impact factor: 3.630

8.  Psychometric validation of the PTSD Checklist-5 among female Filipino migrant workers.

Authors:  Brian J Hall; Paul S Y Yip; Melissa R Garabiles; Chao Kei Lao; Edward W W Chan; Brian P Marx
Journal:  Eur J Psychotraumatol       Date:  2019-02-04

9.  The ABCDE psychological first aid intervention decreases early PTSD symptoms but does not prevent it: results of a randomized-controlled trial.

Authors:  Rodrigo Andrés Figueroa; Paula Francisca Cortés; Humberto Marín; Alvaro Vergés; Rodrigo Gillibrand; Paula Repetto
Journal:  Eur J Psychotraumatol       Date:  2022-03-01

10.  Psychometric properties of the Post Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) in Greek women after cesarean section.

Authors:  Eirini Orovou; Irina Mrvoljak Theodoropoulou; Evangelia Antoniou
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.